# Nutrien Ltd.: Form 40-F for the period ended Dec 31, 2019

- Company: [Nutrien Ltd.](/companies/ntr.md) (CIK 1725964)
- Form: 40-F
- Filed: 2020-02-28
- Accepted by EDGAR: Feb 28, 2020, 12:47 ET
- Period: 2019-12-31
- Accession: 0001193125-20-055383
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1725964/000119312520055383/d815645d40f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1725964/000119312520055383/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2019-01-01 to 2019-12-31 | $20.02bn | ifrs-full:RevenueFromContractsWithCustomers |
| Cost of revenue | 12 months, 2019-01-01 to 2019-12-31 | $13.81bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2019-01-01 to 2019-12-31 | $5.44bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2019-01-01 to 2019-12-31 | $1.86bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2019-01-01 to 2019-12-31 | $316.0m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2019-01-01 to 2019-12-31 | $992.0m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2019-01-01 to 2019-12-31 | $1.70 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2019-01-01 to 2019-12-31 | $1.70 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2019-01-01 to 2019-12-31 | $3.67bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2019-01-01 to 2019-12-31 | $1.73bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2019-12-31 | $671.0m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2019-12-31 | $10.66bn | ifrs-full:CurrentAssets |
| Total assets | at 2019-12-31 | $46.80bn | ifrs-full:Assets |
| Current liabilities | at 2019-12-31 | $9.13bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2019-12-31 | $23.93bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2019-12-31 | $22.87bn | ifrs-full:Equity |
| Shares outstanding | at 2019-12-31 | 572,942,809 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1725964/000119312520055383/d815645d40f.htm

Filed Feb 28, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-055383. Last ingested by Listed: Nov 4, 2026, 19:09 ET. No prices; not investment advice.
